1American Academy. Child and adolescent psychiatry practice parameters for the assessment and treatment of children and adoles- cents with depressive disorder[ J]. J Am Aead Child Adolesc Psychiat ry, 1998,37:63.
2Emslie GJ,J udge R. Trieyclie antidepressants and selective serotonin reuptake inhibitors use during pregnancy in children adolescents and in the elderly[ J ]. Acta Psychiatry Scand ,2000,101:26.
3Wagner KD, Ambrosini P, Rynn M, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder : two randomized controlled trials [ J ]. JAMA, 2003,290 : 1033.
4Ambrosini PJ, Wagner KD, Biederman J, et al. Muhiccnter open-label sear'aline study in adolescent outpatient with major depression [J]. J Am Acad Child Adolese Psychiatry,1999,38:566.
5Baumgartner JL, Emslie GJ, Crismon ML. Citalopram in children and adolescents with depression or anxiety [ J ]. Ann Pharmacother,2002,36 : 1692.
6Courtney DB. Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: A systematic review of published randomized controlled trials [ J]. Can J Psychiatry ,2004,49:557-563.
7Haapasalo-Pesu KM,Vuola T,Lahelma L,et al. Mirtazapine in the treatment of adolescent with major depression : An open-label, multicenter pilot study [ J ]. J Child Adolesc Psychopharmacol, 2004, 14:175-184.
8Dulcan MK, Bregman J, Weller EB, et al. Treatment for childhood and adolescent disorders. In : schatzberg AF, Nemeroff CB, eds. Essentials of clinical pharmacology [ J ]. Washington : American Psychiatry Association,2001,459-517.
9Duff G. Selective serotonin reuptake inhibitors:use in children and adolescents with major depressive disorder[ EB/OL]. 2004- 06-04. http ://www. mca. gov. uk/home. htm.
10The committee for medical products for human use. CHMP meeting on paroxetine and other SSRIs [ EB/OL]. 2005-01-10. http ://medicalnewstoday. com/medicalnew.
